Open access
14,945
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation
Fezolinetant in the treatment of vasomotor symptoms associated with menopause
Herman Depyperea Breast and Menopause Clinic, University Hospital, Ghent, BelgiumCorrespondence[email protected]
View further author information
, View further author information
Christopher Lademacherb Global Development, Astellas Pharma Global Development, Northbrook, IL, USAView further author information
, Emad Siddiquic Medical Affairs, Astellas Pharma Medical and Development, Chertsey, UKView further author information
& Graeme L Fraserd Former Chief Scientific Officer of Ogeda SA, Gosselies, Belgium and Consultant for Astellas Pharma Inc.View further author information
Pages 681-694
|
Received 28 Sep 2020, Accepted 17 Feb 2021, Published online: 12 Jul 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.